JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 1998; 32:942-947
© 1998 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Singh, S. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Singh, S. N.

Prevalence and significance of nonsustained ventricular tachycardia in patients with premature ventricular contractions and heart failure treated with vasodilator therapy

Steven N. Singh, MDa,b,c, Susan G. Fisher, PhDa,b,c, Peter E. Carson, MDa,b,c, Ross D. Fletcher, MDa,b,c the Department of Veterans Affairs CHF STAT Investigators

a VA Medical Center, Washington, DC, USA
b VA Medical Center, Hines, Illinois, USA
c Georgetown University Medical Center, Washington, DC, USA



View larger version (22K):

[in a new window]
 
Figure 1 Kaplan–Meier estimates of (A) overall and (B) sudden death mortality according to the presence or absence of nonsustained ventricular tachycardia (NSVT) and unadjusted for ejection fraction.

 


View larger version (22K):

[in a new window]
 
Figure 2 Kaplan–Meier estimates of (A) overall and (B) sudden death mortality according to NSVT rate less than (slow) or greater than (fast) 120 beats/min. There are no significant differences in either group.

 


View larger version (21K):

[in a new window]
 
Figure 3 Kaplan–Meier estimates of (A) overall and (B) sudden death mortality according to NSVT length less than (short) or greater than (long) 15 consecutive beats. There are no significant differences.

 


View larger version (21K):

[in a new window]
 
Figure 4 Kaplan–Meier estimates of (A) overall and (B) sudden death rates according to the absence (never) or presence (ever) of NSVT on any ambulatory recording throughout the study. There are no significant differences.

 


View larger version (21K):

[in a new window]
 
Figure 5 Unadjusted Kaplan-Meier estimates of (A) overall and (B) sudden death mortality according to the absence (never) or presence (always) of NSVT on ambulatory recording throughout the study.

 





HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 1998 by the American College of Cardiology Foundation.